| Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA RB Lanman, SA Mortimer, OA Zill, D Sebisanovic, R Lopez, S Blau, ... PloS one 10 (10), e0140712, 2015 | 724 | 2015 |
| Validation of a plasma-based comprehensive cancer genotyping assay utilizing orthogonal tissue-and plasma-based methodologies JI Odegaard, JJ Vincent, S Mortimer, JV Vowles, BC Ulrich, KC Banks, ... Clinical Cancer Research 24 (15), 3539-3549, 2018 | 452 | 2018 |
| The Awesome Power of Yeast Evolutionary Genetics: New Genome Sequences and Strain Resources for the Saccharomyces sensu stricto Genus DR Scannell, OA Zill, A Rokas, C Payen, MJ Dunham, MB Eisen, J Rine, ... G3: Genes| Genomes| Genetics 1 (1), 11-25, 2011 | 385 | 2011 |
| The landscape of actionable genomic alterations in cell-free circulating tumor DNA from 21,807 advanced cancer patients OA Zill, KC Banks, SR Fairclough, SA Mortimer, JV Vowles, R Mokhtari, ... Clinical Cancer Research 24 (15), 3528-3538, 2018 | 369 | 2018 |
| Cell-free DNA next-generation sequencing in pancreatobiliary carcinomas OA Zill, C Greene, D Sebisanovic, LM Siew, J Leng, M Vu, AE Hendifar, ... Cancer discovery 5 (10), 1040-1048, 2015 | 287 | 2015 |
| Impact of chromatin structures on DNA processing for genomic analyses L Teytelman, B Özaydın, O Zill, P Lefrançois, M Snyder, J Rine, MB Eisen PloS one 4 (8), e6700, 2009 | 146 | 2009 |
| Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non–small cell lung cancer: Analysis of over 8000 cases PC Mack, KC Banks, CR Espenschied, RA Burich, OA Zill, CE Lee, ... Cancer 126 (14), 3219-3228, 2020 | 142 | 2020 |
| Molecular determinants of response to PD-L1 blockade across tumor types R Banchereau, N Leng, O Zill, E Sokol, G Liu, D Pavlick, S Maund, LF Liu, ... Nature communications 12 (1), 3969, 2021 | 123 | 2021 |
| Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients ST Kim, WS Lee, RB Lanman, S Mortimer, OA Zill, KM Kim, KT Jang, ... Oncotarget 6 (37), 40360, 2015 | 99 | 2015 |
| Somatic genomic landscape of over 15,000 patients with advanced-stage cancer from clinical next-generation sequencing analysis of circulating tumor DNA. OA Zill, S Mortimer, KC Banks, RJ Nagy, D Chudova, C Jackson, A Baca, ... Journal of Clinical Oncology 34 (18_suppl), LBA11501-LBA11501, 2016 | 64 | 2016 |
| Co-evolution of transcriptional silencing proteins and the DNA elements specifying their assembly OA Zill, D Scannell, L Teytelman, J Rine PLoS biology 8 (11), e1000550, 2010 | 47 | 2010 |
| Interspecies variation reveals a conserved repressor of α-specific genes in Saccharomyces yeasts OA Zill, J Rine Genes & development 22 (12), 1704-1716, 2008 | 40 | 2008 |
| The awesome power of yeast evolutionary genetics: new genome sequences and strain resources for the Saccharomyces sensu stricto genus. G3 (Bethesda) 1: 11–25 DR Scannell, OA Zill, A Rokas, C Payen, MJ Dunham, MB Eisen, J Rine, ... Genetics Society of America, 2011 | 32 | 2011 |
| Cell-free DNA next-generation sequencing in pancreatobiliary carcinomas. Cancer Discov. 2015; 5: 1040–1048. doi: 10.1158/2159-8290 OA Zill, C Greene, D Sebisanovic, LM Siew, J Leng, M Vu, AE Hendifar, ... CD-15-0274, 0 | 31 | |
| Single-cell analysis reveals clonally expanded tumor-associated CD57+ CD8 T cells are enriched in the periphery of patients with metastatic urothelial cancer responding to PD … M Fehlings, L Kim, X Guan, K Yuen, A Tafazzol, S Sanjabi, OA Zill, ... Journal for Immunotherapy of Cancer 10 (8), e004759, 2022 | 23 | 2022 |
| ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer RM Johnson, X Qu, CF Lin, LY Huw, A Venkatanarayan, E Sokol, FS Ou, ... Nature communications 13 (1), 5478, 2022 | 22 | 2022 |
| Systematic discovery of neoepitope–HLA pairs for neoantigens shared among patients and tumor types HR Gurung, AJ Heidersbach, M Darwish, PPF Chan, J Li, M Beresini, ... Nature Biotechnology 42 (7), 1107-1117, 2024 | 17 | 2024 |
| Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies AA Lo, A Wallace, D Oreper, N Lounsbury, C Havnar, X Pechuan-Jorge, ... Journal for immunotherapy of cancer 9 (10), e003001, 2021 | 12 | 2021 |
| Evolutionary Analysis of Heterochromatin Protein Compatibility by Interspecies Complementation in Saccharomyces OA Zill, DR Scannell, J Kuei, M Sadhu, J Rine Genetics 192 (3), 1001-1014, 2012 | 9 | 2012 |
| OA06. 01 Clinical Utility of Circulating Tumor DNA (ctDNA) Analysis by Digital next Generation Sequencing of over 5,000 Advanced NSCLC Patients P Mack, K Banks, J Riess, O Zill, S Mortimer, D Chudova, J Odegaard, ... Journal of Thoracic Oncology 12 (1), S263-S264, 2017 | 8 | 2017 |